Side-by-side comparison of AI visibility scores, market position, and capabilities
Invitation Homes, the largest U.S. single-family rental REIT with 85,000+ homes, is pivoting to net seller mode in 2026 and expanding into build-to-rent development.
Invitation Homes was formed in 2012 during the post-financial-crisis housing downturn, acquiring distressed single-family homes at scale, and went public on the NYSE in 2017. Today it is the largest owner of single-family rental homes in the United States, with a portfolio of over 85,000 homes concentrated in high-growth Sun Belt and coastal markets. The portfolio targets the starter and move-up segments, with an average home value around $350,000 and generally under 1,800 square feet, serving residents who prefer the lifestyle of a single-family home without the obligation of ownership.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.